Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Proceedings of the National Academy of Sciences of the United States of America

Volumn 93, Issue 17, 1996, Pages 9235-9240

  Laruelle, Marc ^a,b,c   Abi Dargham, Anissa ^a,b   Van Dyck, Christopher H ^a   Gil, Roberto ^a,b   D'Souza, Cyril D ^a,b   Erdos, Joseph ^a,b   Mccance, Elinore ^a   Rosenblatt, William ^a   Fingado, Christine ^a,b   Zoghbi, Sami S ^b   Baldwin, Ronald M ^a,b   Seibyl, John P ^a   Krystal, John H ^a,b   Charney, Dennis S ^a,b   Innis, Robert B ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE; TRACER;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG RECEPTOR BINDING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RADIOIODINATION; RECEPTOR DENSITY; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AMPHETAMINE; ANIMALS; BENZAMIDES; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; PAPIO; PSYCHOSES, SUBSTANCE-INDUCED; PYRROLIDINES; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029787944     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.93.17.9235     Document Type: Article

References (51)

1. Rossum, V. (1966) Arch. Int. Pharmacodyn. Ther. 160, 492-494.
2. Angrist, B. M. & Gershon, S. (1970) Biol. Psychiatry 2, 95-107.
3. Davis, K. L., Kahn, R. S., Ko, G. & Davidson, M. (1991) Am. J. Psychiatry 148, 1474-1486.
4. Burt, D. R., Creese, I. & Snyder, S. S. (1977) Science 196, 326-328.
5. Seeman, P. (1987) Synapse 1, 133-152.
6. Wong, D. F., Wagner, H. N., Tune, L. E., Dannals, R. F., Pearlson, G. D., Links, J. M., Tamminga, C. A., Broussolle, E. P., Ravert, H. T., Wilson, A. A., Toung, J. K., Malat, J., Williams, J. A., O'Tuama, L. A., Snyder, S. H., Kuhar, M. J. & Gjedde, A. (1986) Science 234, 1558-1563.
7. Tune, L. E., Wong, D. F., Pearlson, G., Strauss, M., Young, T., Shaya, E. K., Dannals, R. F., Wilson, A. A., Ravert, H. T., Sapp, J., Cooper, T., Chase, G. A. & Wagner, H. N. (1994) Psychiatry Res. 49, 219-237.
8. Farde, L., Wiesel, F., Stone-Elander, S., Halldin, C., Nordström, A. L., Hall, H. & Sedvall, G. (1990) Arch. Gen. Psychiatry 47, 213-219.
9. Martinot, J. I., Paillère-Martinot, M. L., Loc'h, C., Hardy, P., Poirier, M. F., Mazoyer, B., Beaufils, B., Mazièfre, B., Alliaire, J. F. & Syrota, A. (1991) Br. J. Psychiatry 158, 346-350.
10. Hietala, J., Syvälahti, E., Vuorio, K., Nagren, K., Lehikoinen, P., Ruotsalainen, U., Räkköläinen, V., Lehtinen, V. & Wegelius, U. (1994) Arch. Gen. Psychiatry 51, 116-123.
11. Pilowsky, L. S., Costa, D. C., Ell, P. J., Verhoeff, N. P. L. G., Murray, R. M. & Kerwin, R. W. (1994) Br. J. Psychiatry 164, 16-26.
12. Nordström, A. L., Farde, L., Erikson, L. & Halldin, C. (1995) Psychiatry Res. 61, 67-83.
13. Carlsson, A. (1988) Neuropsychopharmacology 1, 179-186.
14. Meltzer, H. (1989) Psychopharmacology 99, S18-S27.
15. Köhler, C., Fuxe, K. & Ross, S. B. (1981) Eur. J. Pharmacol. 72, 397-402.
16. Van der Werf, J. F., Sebens, J. B., Vaalburg, W. & Korf, J. (1986) Eur. J. Pharmacol. 87, 259-270.
17. Ross, S. B. & Jackson, D. M. (1989) Naunyn-Schmiedebergs Arch. Pharmakol. 340, 6-12.
18. Logan, J., Dewey, S. L., Wolf, A. P., Fowler, J. S., Brodie, J. D., Angrist, B., Volkow, N. D. & Galley, S. J. (1991) Synapse 9, 195-207.
19. Innis, R. B., Malison, R. T., Al-Tikriti, M., Hoffer, P. B., Sybirska, E. H., Seibyl, J. P., Zoghbi, S. S., Baldwin, R. M., Laruelle, M. A., Smith, E., Charney, D. S., Heninger, G., Elsworth, J. D. & Roth, R. H. (1992) Synapse 10, 177-184.
20. Dewey, S. L., Smith, G. S., Logan, J. & Brodie, J. D. (1993) Neuropsychopharmacology 8, 371-376.
21. Farde, L., Nordström, A. L., Wiesel, F. A., Pauli, S., Halldin, C. & Sedvall, G. (1992) Arch. Gen. Psychiatry 49, 538-544.
22. Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., Burr, G., Cooper, T. & Wolf, A. P. (1994) Synapse 16, 255-262.
23. Kung, H. F., Kasliwal, R., Pan, S., Kung, M.-P., Mach, R. H. & Guo, Y.-Z. (1988) J. Med. Chem. 31, 1039-1043.
24. Laruelle, M., Iyer, R. N., Al-Tikriti, M. S., Zea-Ponce, Y., Malison, R., Zoghbi, S. S., Baldwin, R. M., Kung, H. F., Charney, D. S., Hoffer, P. B., Innis, R. B. & Bradberry, C. W. (1996) Synapse, in press.
25. Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea-Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., Kung, H. F. & Innis, R. B. (1995) J. Nucl. Med. 36, 1182-1190.
26. Lieberman, J. A., Kane, J. M. & Alvir, J. (1987) Psychopharmacology 91, 415-433.
27. Lieberman, J. A., Kinon, B. L. & Loebel, A. D. (1990) Schizophr. Bull. 16, 97-110.
28. Gandelman, M. S., Baldwin, R. M., Zoghbi, S. S., Zea-Ponce, Y. & Innis, R. B. (1994) J. Pharm. Sci. 83, 1014-1019.
29. Kay, S. R., Fiszbein, A. & Opler, L. A. (1987) Schizophr. Bull. 13, 261-276.
30. van Kammen, D. P. & Murphy, D. L. (1975) Psychopharmacologia 44, 215-224.
31. Lidow, M. S., Goldman-Rakic, P. S., Rakic, P. & Innis, R. B. (1989) Proc. Natl. Acad. Sci. USA 86, 6412-6416.
32. Seibyl, J., Woods, S., Zoghbi, S., Baldwin, R., Dey, H., Goddard, A., Zea-Ponce, Y., Zubal, G., Germinne, M., Smith, E., Heninger, G. R., Charney, D. S., Kung, H., Alavi, A., Hoffer, P. & Innis, R. (1992) J. Nucl. Med. 33, 1964-1971.
33. Overall, J. E. & Gorham, D. R. (1962) Psychol. Rep. 10, 799-812.
34. Ichikawa, J. & Meltzer, H. Y. (1992) Brain Res. 574, 98-104.
35. Gejman, P. V., Ram, A., Gelernter, J., Friedman, E., Cao, Q., Pickar, D., Blum, K., Noble, E. P., Kranzler, H. R., O'Malley, S., Hamer, D. h., Whitsitt, F., Rao, P., DeLisi, L. E., Virkkunen, M., Linoila, M., Goldman, D. & Gershon, E. S. (1994) J. Am. Med. Assoc. 271, 204-208.
36. Lee, T., Seeman, P., Tourtelotte, W. W., Farley, I. J. & Hornykiewicz, O. (1978) Nature (London) 274, 897-900.
37. Cross, A. J., Crow, T. J., Ferrier, I. N., Johnstone, E. C., Mc-Creadie, R. M., Owen, F., Owens, D. G. C. & Poulter, M. (1983) J. Neural Transm. Suppl. 18, 265-272.
38. Azzuro, A. J. & Rutledge, C. O. (1973) Biochem. Pharmacol. 22, 2801-2813.
39. Sulzer, D., Chen, T. K., Lau, Y. Y., Kristensen, H., Rayport, S. & Ewing, A. (1995) J. Neurosci. 15, 4102-4108.
40. Horn, A. S., Coyle, J. T. & Snyder, S. H. (1970) Mol. Pharmacol. 7, 66-90.
41. Green, A. L. & El Haut, M. J. (1978) J. Pharm. Pharmacol. 30, 262-263.
42. Uretsky, N. J. & Snodgrass, S. R. (1977) J. Pharmacol. Exp. Ther. 202, 565-580.
43. Reith, J., Benkelfat, C., Sherwin, A., Yasuhara, Y., Kuwabara, H., Andermann, F., Bachneff, S., Cumming, P., Diksic, M., Dyve, S. E., Etienne, P., Evans, A. C, Lal, S., Shevell, M., Savard, G., Wong, D. F., Chouinard, G. & Gjedde, A. (1994) Proc. Natl. Acad. Sci. USA 91, 11651-11654.
44. Retaux, S., Besson, M. J. & Penit-Soria, J. (1991) Neuroscience 43, 323-329.
45. Deutch, A. Y. (1993) J. Neural Transm. 91, 197-221.
46. Karreman, M. & Moghaddam, B. (1996) J. Neurochem. 66, 589-598.
47. Roberts, A. C., Desalvia, M. A., Wilkinson, L. S., Collins, P., Muir, J. L., Everitt, B. J. & Robbins, T. W. (1994) J. Neurosci. 14, 2531-2544.
48. Schwarz, R. D., Uretsky, N. J. & Bianchine, J. R. (1980) J. Neurochem. 35, 1120-1127.
49. Weinberger, D. R. (1987) Arch. Gen. Psychiatry 44, 660-669.
50. Benes, F. M., McSparren, J., Bird, E. D., Vincent, S. L. & San-Giovani, J. P. (1991) Arch. Gen. Psychiatry 48, 996-1001.
51. Lidsky, T. I. (1995) Schizophr. Bull. 21, 67-74.